Wellington Management's Biotechnology Portfolio

Ventyx is a biopharmaceutical company focused on advancing oral therapies for patients living with autoimmune and inflammatory disorders.

RayzeBio is a pharmaceuticals company that develops targeted radiopharmaceutical drugs for cancer.

Korsana Biosciences develops THETA-enabled antibody therapies for neurodegenerative diseases including Alzheimer’s.

Synapse Energy Economics is a consulting firm providing economic and policy analysis for the electric power sector.

Day One Biopharmaceuticals develops targeted therapies to treat people with life-threatening diseases.

Strata Oncology is a precision oncology company dedicated to transforming cancer care.

Scorpion Therapeutics is a clinical-stage oncology company that specializes in precision medicine for cancer patients.

Element Biosciences develops genomic sequencing and multiomics technologies used in drug discovery, and diagnostic applications.

Upstream Bio focuses on developing an antibody therapy for the treatment of severe asthma.

Blueprint Medicines develops precision therapies for genomically defined cancers and rare diseases.

Black Diamond Therapeutics is a medical company focused on analyzing genetically defined cancers.

Nuvation Bio is a global biopharmaceutical company focusing on unmet needs in oncology.

RQ Bio is a biotechnology company that develops medicine based on potent broad-spectrum mAbs to provide immunity to viral infections.

Entrada Therapeutics is a developer of novel therapeutics intended to treat devastating diseases.

Scribe Therapeutics is a biotech company that develops and engineers new therapeutics based on CRISPR molecules.

Dyne Therapeutics is a developer of targeted therapies intended for serious muscle diseases.

Moderna Therapeutics is a biotechnology company that develops medicines and vaccines based on messenger RNA (mRNA) technology.

Fore Biotherapeutics is a precision oncology company specializing in cancer therapies guided by functional genomics.

Allena Pharmaceuticals develops and commercializes non-systemic protein therapeutics to treat metabolic and orphan diseases.

CARGO Therapeutics develops an adoptive cell therapy to benefit patients from potentially curative treatment options.

Apogee Therapeutics is a biotechnology company that offers therapies for immunological and inflammatory disorders.

Boundless Bio is a precision oncology company that develops therapeutics directed against extrachromosomal DNA in aggressive cancers.

Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.

Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.

Heartflow is a medical technology company that provides various methods of diagnosis and treatment of cardiovascular disease.

Generation Bio is a biotechnology company that develops genetic medicines to treat genetic disorders.

Freeline is a biotechnology company that develops transformative gene therapies for systemic debilitating diseases.

Chroma Medicine is a biotechnology company that develops genetic medicines for the treatment of genetic disorders.

Synthego is a genome engineering company that enables access to CRISPR to accelerate life science research and development.

Aligos Therapeutics is discovering and developing new classes of molecules that interact directly with disease-causing modalities.

Galecto is a clinical stage biotechnology company focused on the development of novel treatments for fibrosis and cancer.

Tubulis generates antibody-drug conjugates with unique properties for solid tumor indications.

Avalyn Pharma is a biopharma company developing therapies for the treatment of idiopathic pulmonary fibrosis and other respiratory diseases.

Atsena Therapeutics is a clinical-stage gene therapy company that develops novel treatments for inherited forms of blindness.

Helicore Biopharma is a biopharmaceutical company that discovers and develops novel weight-loss therapeutics.

MBX Biosciences is a preclinical-stage biotech company that creates therapies to treat rare endocrine diseases.

Bluejay Therapeutics is a private biopharmaceutical company focused on the development of cures for infectious diseases.

Asher Bio is a biotechnology company that specializes in the fields of therapeutics builds better immunotherapy for cancer.

Alkeus Pharmaceuticals is a Boston-based startup focused on treatments for serious ophthalmic conditions.

Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.

Crescent Biopharma is a biotechnology firm focused on developing novel precision-engineered medicines.

SiteOne Therapeutics develops groundbreaking non-opioid treatments for acute, neuropathic, visceral, and musculoskeletal pain.

GBT is a clinical-stage biopharmaceutical company developing a therapy for sickle cell disease.

Kymera Therapeutics is a biotechnology company that specializes in the field of targeted protein degradation.

Caldera Therapeutics is a biotech company engaged in the development of bispecific antibody CLD-423 for inflammatory bowel disease (IBD).

Nuvalent is a biopharmaceutical company that develops targeted therapies for cancer by designing small-molecule medicines.

Beta Bionics is a biotechnology company that provides software to reduce the burden of diabetes care.

Centessa Pharmaceuticals is a pharmaceutical company that focuses on drug development to address significant medical needs.

Cogent Biosciences is a biotechnology company that develops therapies for solid cancer tumors.

Arcus Biosciences is a biopharmaceutical company that discovers, develops, and commercializes novel therapies for the treatment of cancer.

Nurix Therapeutics is a biopharmaceutical company that focuses on the development and discovery of small molecule drugs.

Disc Medicine is a biopharmaceutical company that develops therapies for hematologic diseases and rare blood disorders.

Angitia Biopharmaceuticals develops biologic therapies for musculoskeletal diseases.

Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.

nChroma Bio is a cutting-edge biotechnology business that is developing targeted in vivo delivery systems as well as best-in-class cargo.

Verve Therapeutics is a clinical-stage biotechnology company developing genetic medicines for cardiovascular disease.

Gracell Biotechnologies is a developer of cancer immune therapy designed to treat cancer.

NiKang Therapeutics is a biotech company focused on discovering and developing small molecule oncology medicines.

Satsuma Pharmaceuticals is a clinical-stage biopharmaceutical company engaged in developing a novel therapeutic product.

Artiva Biotherapeutics is a biotech company focused on developing and commercializing allogeneic natural killer (NK) cell therapies.

Gemini Therapeutics focuses on genetically-defined dry age-related macular degeneration (AMD) and associated rare genetic diseases.

Design Therapeutics is a biotechnology company developing a new class of therapies for serious degenerative disorders.

LianBio aims to develop and accelerate availability of paradigm-shifting medicines to patients in China.

PMV Pharmaceuticals is a developer of p53-targeted small molecule drugs for the treatment of cancer.

Atreca develops a technology to identify the set of antibodies produced during an immune response, without prior knowledge of an antigen.

Forty Seven is a clinical-stage immuno-oncology company that is developing therapies targeting cancer immune evasion pathways.

NEON Therapeutics is focused on unlocking the full potential of the immune system to recognize and attack cancer.

Nightstar is biopharmaceutical company, focused on developing gene therapies for retinal dystrophies.